Search results for "Randomized controlled trials"

showing 10 items of 449 documents

Quality of reporting in abstracts of RCTs published in emergency medicine journals: a protocol for a systematic survey of the literature

2017

Introduction The quality of reporting of abstracts of randomised controlled trials (RCTs) in major general medical journals and in some category-specific journals was shown to be poor before the publication of the ConsolidatedStandards of ReportingTrials (CONSORT) extension for abstracts in 2008, and an improvement in the quality of reporting of abstracts was observed after its publication. The effect of the publication of the CONSORT extension for abstracts on the quality of reporting of RCTs in emergency medicine journals has not been studied. In this paper, we present the protocol of a systematic survey of the literature, aimed at assessing the quality of reporting in abstracts of RCTs p…

Research Reportmedicine.medical_specialtyResearch methodologySystematic surveymedia_common.quotation_subjectAlternative medicineAccident & emergency medicine03 medical and health sciences0302 clinical medicineQuality of reportingProtocolMedicineHumansQuality (business)030212 general & internal medicine1506Abstractmedia_commonRandomized Controlled Trials as TopicProtocol (science)Research ethicsImpact factorbusiness.industryPublicationsConsolidated Standards of Reporting Trials030208 emergency & critical care medicineGeneral Medicinehumanities1691Statistics &research methodsEmergency medicineEmergency MedicineMedline databasebusinessBMJ Open
researchProduct

Cluster-Randomized Studies.

2018

Background Cluster-randomized trials (CRT) are needed to compare interventions that are allocated to entire groups of subjects, rather than to individuals. Publications about CRT have become steadily more common over the past decade. Readers of such publications should be able to categorize and interpret the findings of CRT correctly while considering the methodological requirements applicable to this type of study. Methods This review is based on a selection of pertinent literature and on the authors' expertise. CRT-specific methodological aspects of the planning, performance, and interpretation of studies are discussed. Results Readers of publications on CRT should check whether due consi…

Research designFuture studiesBiomedical Researchbusiness.industryMEDLINEPsychological interventionConsolidated Standards of Reporting TrialsGuidelines as TopicGeneral MedicineReview Article01 natural sciences010104 statistics & probability03 medical and health sciences0302 clinical medicineCategorizationResearch DesignSelection (linguistics)MedicineCluster AnalysisHumans030212 general & internal medicine0101 mathematicsbusinessCognitive psychologyRandomized Controlled Trials as TopicDeutsches Arzteblatt international
researchProduct

Quality assessment of randomized controlled trial abstracts on drug therapy of periodontal disease from the abstracts published in dental Science Cit…

2020

Background Randomized controlled trials (RCTs) provide the highest level of evidence and are likely to influence clinical decision-making. This study evaluated the reporting quality of RCT abstracts on drug therapy of periodontal disease and assessed the associated factors. Material and Methods The Pubmed database was searched for periodontal RCTs published in Science Citation Indexed (SCI) dental journals from 2010/01/01 to 2019/07/17. Information was extracted from the abstracts according to a modified Consolidated Standards of Reporting Trials (CONSORT) guideline checklist. The data was analyzed using descriptive statistical analysis and the statistical associations were examined using t…

Research designmedicine.medical_specialtyAbstracting and IndexingMEDLINElaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawInternal medicineHumansMedicinePeriodontologyGeneral DentistryPeriodontal DiseasesRandomized Controlled Trials as TopicIntention-to-treat analysisbusiness.industryResearchConsolidated Standards of Reporting Trials030206 dentistryGuideline:CIENCIAS MÉDICAS [UNESCO]ChecklistConfidence intervalChecklistOtorhinolaryngologyResearch DesignUNESCO::CIENCIAS MÉDICASSurgeryPeriodicals as Topicbusiness
researchProduct

SEQUENTIALLY ADJUSTED RANDOMIZATION TO FORCE BALANCE IN CONTROLLED TRIALS WITH UNKNOWN PREVALENCE OF COVARIATES: APPLICATION TO ALCOHOLISM RESEARCH

2005

In treatment outcome studies with small to medium sample sizes (n200), the balance of groups with regard to important factors, which sometimes occur at low prevalence, is indispensable for adequate interpretation. This study tested a method for use in clinical alcoholism research, an uncomplicated procedure for satisfactory randomization of patients to different treatments, taking into account relevant background variables.An easily applicable modification of Efron's biased coin method for the randomization of treatments within strata of unknown but low prevalence was compared with the original approach and alternative methods by computer simulation (10,000 runs). An application example for…

Restricted randomizationChi-Square DistributionRandomizationTreatment outcomeGeneral MedicineForce balanceClinical trialAlcoholismResearch DesignSample size determinationCovariateStatisticsPrevalenceHumansComputer SimulationSpecial casePsychologySocial psychologyRandomized Controlled Trials as TopicAlcohol and Alcoholism
researchProduct

The impact of deep vein thrombosis in critically ill patients: a meta-analysis of major clinical outcomes

2015

Background. Critically ill patients appear to be at high risk of developing deep vein thrombosis (DVT) and pulmonary embolism during their stay in the intensive care unit (ICU). However, little is known about the clinical course of venous thromboembolism in the ICU setting. We therefore evaluated, through a systematic review of the literature, the available data on the impact of a diagnosis of DVT on hospital and ICU stay, duration of mechanical ventilation and mortality in critically ill patients. We also tried to determine whether currently adopted prophylactic measures need to be revised and improved in the ICU setting. Materials and methods. MEDLINE and EMBASE databases were searched up…

RiskCritical IllnessIntensive Care UnitCritically ill patients; Deep vein thrombosis; Meta-analysis; Outcomes; Cohort Studies; Hospital Mortality; Humans; Intensive Care Units; Length of Stay; Pulmonary Embolism; Randomized Controlled Trials as Topic; Research Design; Respiration Artificial; Risk; Thrombophilia; Treatment Outcome; Venous Thrombosis; Critical Illness; Hematology; Immunology and AllergyReviewDeep Vein Thrombosis Critically Ill Patients outcomes metanalysisCohort StudiesDeep vein thrombosiImmunology and AllergyHumansThrombophiliaMeta-analysiVenous ThrombosiHospital MortalityOutcomeRandomized Controlled Trials as TopicVenous ThrombosisHematologyLength of StayRespiration ArtificialIntensive Care UnitsTreatment OutcomeResearch DesignCritical IllneCritically ill patientCohort StudiePulmonary EmbolismHuman
researchProduct

Sorafenib for Hepatocellular Carcinoma: From Randomized Controlled Trials to Clinical Practice.

2015

Hepatocellular carcinoma is a challenging malignancy of global importance. It is the sixth most common solid malignancy and the third leading cause of cancer-related death, worldwide. Curative treatments at early stages include liver transplantation, resection and percutaneous ablation, while transarterial chemoembolization can improve survival in patients with intermediate tumor stage. Patients with mild, related symptoms and/or macrovascular invasion or extrahepatic spread are classified under the advanced stage. The standard of care in this group is sorafenib, an inhibitor of Raf kinase and vascular endothelial growth factor receptor, whose effectiveness has been proven by 2 recent rando…

SHARPOncologyHepatocellular carcinomamedicine.medical_treatmentOLTLiver transplantationGastroenterologyLiver cirrhosilaw.inventionAntineoplastic AgentRandomized controlled triallawPractice Patterns Physicians'Randomized Controlled Trials as TopicNexavarMedicine (all)Liver NeoplasmsGastroenterologyGeneral MedicineSorafenibLocoregional therapiePercutaneous ethanol injectionLiver NeoplasmRaf kinaseHepatocellular carcinomaLiver cancerLiver cancerHumanmedicine.drugSorafenibNiacinamidemedicine.medical_specialtyCarcinoma HepatocellularAntineoplastic AgentsMalignancyTransarterial chemoembolizationInternal medicinemedicineCarcinomaChemotherapyHumansChemoembolization Therapeuticbusiness.industryPhenylurea CompoundsRadiofrequency ablationResectionmedicine.diseaseBCLCPercutaneous ethanol injectionbusinessDigestive diseases (Basel, Switzerland)
researchProduct

Efficacy of Low-Dose Paroxetine for the Treatment of Hot Flushes in Surgical and Physiological Postmenopausal Women: Systematic Review and Meta-Analy…

2019

Background and Objectives: Hot flushes and sleep disturbances are the most common vasomotor symptoms (VMS) reported by postmenopausal women. Hormonal treatment is to date referred to as the gold standard approach but not suitable for all the patients. Alternative treatments are needed in case of a contraindication to menopausal hormone therapy (MHT), adverse side effects, and poor compliance. Paroxetine salt is the only nonhormonal medication approved by the US Food and Drug Administration for the management of VMS. Nonetheless, few trials with low consensus are available about this topic. In this review, we aimed to evaluate the efficacy of low-dose paroxetine therapy in the treatment of v…

Sleep Wake Disordersmedicine.medical_specialtyMedicine (General)Ovariectomyvasomotor symptomsefficacymenopauseReviewPlacebosleep disturbanceslaw.inventionR5-920Randomized controlled triallawInternal medicinemedicineHumanshot flusheAdverse effectContraindicationRandomized Controlled Trials as TopicVasomotorbusiness.industryGeneral Medicinemedicine.diseasesleep disturbanceParoxetineMenopausePostmenopauseParoxetineMeta-analysisefficacy; hot flushes; menopause; paroxetine; sleep disturbances; vasomotor symptomsHot FlashesFemalehot flushesbusinessSelective Serotonin Reuptake Inhibitorsmedicine.drugMedicina
researchProduct

HCC therapies--lessons learned.

2014

The antiangiogenic multikinase inhibitor sorafenib was the first systemic agent to demonstrate a significant improvement in the overall survival of patients with advanced hepatocellular carcinoma (HCC), thereby introducing molecularly-targeted therapy in a therapeutic field of unmet needs. However, survival benefits for patients on sorafenib treatment are modest in clinical practice and advancing the field is far more challenging than initially anticipated. Molecular and clinical heterogeneity diminishes signals of potential activity in unselected populations, and underlying liver cirrhosis seals the fate of many novel targeted agents by causing relevant toxicity and mortality. The failure …

SorafenibLiver Cirrhosismedicine.medical_specialtyPhase iii trialsCarcinoma HepatocellularHepatologybusiness.industryLiver NeoplasmsGastroenterologymedicine.diseaseSystemic therapydigestive system diseasesSurgeryClinical Trials Phase III as TopicHepatocellular carcinomamedicineHumansIntensive care medicinebusinessmedicine.drugRandomized Controlled Trials as TopicNature reviews. Gastroenterologyhepatology
researchProduct

Systemic therapy for intermediate and advanced hepatocellular carcinoma: Sorafenib and beyond.

2018

The hepatocellular carcinoma (HCC) treatment landscape changed a decade ago, with sorafenib demonstrating survival benefit in the first-line setting and becoming the first systemic therapy to be approved for HCC. More recently, regorafenib and nivolumab have received approval in the second-line setting after sorafenib, with further positive phase 3 studies emerging in the first line (lenvatinib non-inferior to sorafenib) and second line versus placebo (cabozantinib and ramucirumab). A key recommendation in the management of patients receiving sorafenib is to promote close communication between the patient and the physician so that adverse events (AEs) are detected early and severe AEs can b…

SorafenibOncologyNiacinamidemedicine.medical_specialtyCarcinoma HepatocellularCabozantinibAntineoplastic Agentsurologic and male genital diseasesRamucirumab03 medical and health scienceschemistry.chemical_compound0302 clinical medicineInternal medicineRegorafenibmedicineHumansheterocyclic compoundsRadiology Nuclear Medicine and imagingAdverse effectneoplasmsProtein Kinase InhibitorsRandomized Controlled Trials as TopicClinical Trials as Topicbusiness.industryPhenylurea CompoundsLiver NeoplasmsGeneral MedicineSorafenibmedicine.diseasefemale genital diseases and pregnancy complicationsdigestive system diseasesOncologychemistry030220 oncology & carcinogenesisHepatocellular carcinoma030211 gastroenterology & hepatologyNivolumabLenvatinibbusinessmedicine.drugCancer treatment reviews
researchProduct

Effect of a common exercise programme with an individualised progression criterion based on the measurement of neuromuscular capacity versus current …

2021

IntroductionHigh-load resistance training has shown positive effects in pain and function in lower limb tendinopathies. However, some authors suggest that current exercise programmes produce an increase in tolerance to load and exercise in general but without fixing some existing issues in tendinopathy. This may indicate the need to include training aspects not currently taken into account in the current programmes. The main objective of this study will be to compare the effect of a common exercise protocol for the three predominant lower limb tendinopathies (Achilles, patellar and gluteal), based on an individualised control of the dose and training of specific aspects of the neuromuscular…

Sports medicinehipFerides i lesions Tractamentknee:Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings]Quality of lifeInformed consent:Anatomy::Body Regions::Extremities::Lower Extremity [Medical Subject Headings]:Anatomy::Musculoskeletal System::Tendons::Achilles Tendon [Medical Subject Headings]:Analytical Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Rehabilitation::Exercise Therapy [Medical Subject Headings]1506Randomized Controlled Trials as Topic:Analytical Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Evaluation Studies as Topic::Clinical Trials as Topic::Controlled Clinical Trials as Topic::Randomized Controlled Trials as Topic [Medical Subject Headings]foot & ankleMedicina física y rehabilitaciónRrehabilitation medicineGeneral MedicineExercise TherapyTreatment OutcomeLower Extremity:Anthropology Education Sociology and Social Phenomena::Social Sciences::Quality of Life [Medical Subject Headings]MedicineRodillamedicine.medical_specialtyBest practiceCaderaRehabilitation MedicineIntervention (counseling)medicineHumans1727:Analytical Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Prognosis::Treatment Outcome [Medical Subject Headings]Protocol (science)sports medicineFootbusiness.industryPieMedicina deportivamedicine.diseaseClinical trialTendinopathy:Diseases::Musculoskeletal Diseases::Muscular Diseases::Tendinopathy [Medical Subject Headings]Physical therapyQuality of LifeTobilloAnkleTendinopathyTendinitisbusiness
researchProduct